In The News - SFJ Pharmaceuticals
 

In the News

Abituzumab in Metastatic Colorectal Cancer

Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group Agreement enables Merck KGaA, Darmstadt, Germany, to further develop abituzumab through a novel risk-sharing collaboration…